Cargando…
Use of human protein C concentrates in the treatment of patients with severe congenital protein C deficiency
Protein C is one of the major inhibitors of the coagulation system that downregulate thrombin generation. Severe congenital protein C deficiency leads to a hypercoagulability state that usually presents at birth with purpura fulminans and/or severe venous and arterial thrombosis. Recurrent thromboti...
Autores principales: | Kroiss, Sabine, Albisetti, Manuela |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846144/ https://www.ncbi.nlm.nih.gov/pubmed/20376174 |
Ejemplares similares
-
Severe congenital protein C deficiency: the use of protein C concentrates (human) as replacement therapy for life-threatening blood-clotting complications
por: Knoebl, Paul N
Publicado: (2008) -
Prenatal genetic testing for familial severe congenital protein C deficiency
por: Tairaku, Shinya, et al.
Publicado: (2015) -
Congenital protein C deficiency and thrombosis in a dog
por: Kelly, Darren, et al.
Publicado: (2020) -
Aortic Mural Thrombus Associated with Congenital Protein C Deficiency in an Elderly Patient
por: Ueda, Kazuki, et al.
Publicado: (2020) -
Surgical treatment of traction retinal detachment associated with compound heterozygous congenital protein C deficiency
por: Kurihara, Tomoki, et al.
Publicado: (2023)